CTO’s Insider Buy Signals Confidence in Ceribell’s Rapid‑EEG Growth Potential
CTO’s rule‑based buy at $2.24 shows confidence in Ceribell’s rapid, wireless EEG system—yet investors weigh its high volatility, negative earnings and payer‑reimbursement risks.
4 minutes to read